You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

18 May 2018

Access to hepatitis C treatment increasing among people living with HIV.

Increasing numbers of people co-infected with HIV and hepatitis C (HCV) are accessing treatment for HCV as antivirals become more effective – but challenges beyond increasing access, remain.

0
10 May 2018

HIV self-testers can use and interpret rapid tests as easily as a health worker

Self-testers are able to perform HIV tests and interpret the results as accurately as healthcare workers, a new evidence review has found.

0
04 May 2018

6 things you need to know about sexual consent

You’re dreaming of exciting, mind-blowing, fun, sweet, heart-pumping sex with someone... but hold on, what’s sexual consent? And how does it work ‘in the moment’?

0
02 May 2018

HIV response in Nigeria buckles under pressure of continued conflict with Boko Haram

New comparison reveals significant drops in HIV service provision, as Nigeria’s Borno State feels the impact of years of armed conflict with Boko Haram.  

0
27 April 2018

Tenofovir is safe for pregnant women living with HIV and their babies

Reassurance for women living with HIV as commonly prescribed HIV drug deemed as safe as other regimes.

0
23 April 2018

First global comparison reveals stark health inequalities among adolescents born with HIV.

New research highlights significant gaps in health outcomes for adolescents born with HIV across the world – but paints a hopeful picture for the future as treatment access expands.

0
19 April 2018

Safe and effective $300 hepatitis C treatment a global game-changer

Interim clinical trial results offer hope to people living with hepatitis C who stand to benefit from reduced price treatment, including the 2.3 million people who have HIV co-infection.

0
17 April 2018

The girl effect: how teenage boys are likely to listen to girls over VMMC

Adolescent girls have an important role to play in influencing adolescent boys’ decision to undergo voluntary medical male circumcision (VMMC), new research suggests.

0
12 April 2018

India could shift from efavirenz to dolutegravir for HIV treatment – at no extra cost, new research suggests

Researchers recommend dolutegravir (DTG)‐based antiretrovirals should become the first option for HIV treatment in India, following a study into DTG’s cost-effectiveness.

0
09 April 2018

HIV criminalisation deters men from testing and can increase HIV transmission rates

Findings show that fear of prosecution can drive new infections, as it puts men off knowing their status.

0